Brief: Armata Pharmaceuticals Posts Q4 Revenue $500,000
18/03/2021 21:30
March 18 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2020 RESULTS AND PROVIDES GENERAL CORPORATE UPDATE
* Q4 REVENUE $500,000
* Q4 REVENUE ESTIMATE $703,000 -- REFINITIV IBES DATA
* QUARTERLY LOSS PER SHARE $0.36
Source text for Eikon: ID:nPnbgR8qsa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles